甲状腺のおはなし 甲状腺と食事、薬
診療時間 交通アクセス
院内案内 院長紹介
TOPへもどる

主 な 職 歴

大阪大学細胞工学センター助手  

京都大学第二内科医員        
日本学術振興会特別研究員
京都大学大学院医学研究科臨床病態検査学講座 講師 
京都大学医学部附属病院検査部講師

京都大学臨床病態医科学(第二内科)非常勤講師 (元)
京都大学糖尿病内分泌栄養内科)非常勤講師 (現)

   院 長  須 川 秀 夫

 丹羽幸一編著「ご近所の優良開業医 T、U」に、生活習慣病に
強い優良開業医として紹介されました

 日経メディカル 「ガイドライン 外来診療 2005」 の執筆を分担しています

最新内分泌代謝学(中尾一和京大教授編集主幹)の執筆を分担しています

免 許 / 資 格

日本甲状腺学会専門医
日本内分泌学会内分泌代謝科(内科)専門医
日本内科学会認定医

日本医師会認定産業医
日本医師会認定健康スポーツ医
                
    このたび、須川秀夫院長が監訳した医学書が出版されました。
    甲状腺の病気についてのわかりやすい解説書です。ご参考にどうぞ!
 
   「我が家のお医者さんシリーズ18: よくわかる甲状腺疾患 一灯舎 オーム社発行」 

日本臨床内科医会

 

学 会 活 動 歴

日本内科学会(現 近畿支部評議員)

日本内分泌学会 (現 代議員)

日本甲状腺学会(現 評議員)

日本癌学会

日本臨床病理学会(現 近畿支部評議員)

日本糖尿病学会

日本臨床免疫学会

日本東洋医学会

日本細胞生物学会

 

主な研究活動

(発 表 論 文)

1. Hideo Sugawa, Naoko Imamoto, Mari Wataya-Kaneda and Tsuyoshi Uchida.    Foreign protein can be carried into the nucleus of mammalian cell by conjugation with nucleoplasmin. Experimental Cell Research  159 (1985) 419-429  

2. Hideo Sugawa, Tsuyoshi Uchida, Yoshihiro Yoneda, Masahiro Ishiura and Yoshio Okada.   Large macromolecules can be introduced into cultured mammalian cells using erythrocyte membrane   vesicles. Experimental Cell Research 159 (1985) 410-418

3. Hideo Sugawa and Tsuyoshi Uchida.   Inhibition of RNA nucleo-cytoplasmic translocation by anti-nucleus antibody.    Biochemical and Biophysical Research Communications  127 (1985) 864-870

4. Mahito Nakanishi, Tsuyoshi Uchida, Hideo Sugawa, Masahiro Ishiura and Yoshio Okada.  Efficient introduction of contents of liposomes into cells using HVJ(Sendai virus).     Experimental Cell Research  159 (1985) 399-409 

5. Tamotsu Yoshimori, Masaaki Yamada, Hideo Sugawa, Tsuyoshi Uchida and Yoshio Okada. Monoclonal antibodies against Diphtheria toxin fragment A.    Experimental Cell Research  151 (1984) 344-353   

6. Mari Wataya-Kaneda, Yasushi Kaneda, Takashi Sakurai, Hideo Sugawa and Tsuyoshi Uchida.   A monoclonal antibody against the nucleus reveals the presence of a common protein in the nuclear    envelope, the perichromosomal region, and cytoplasmic vesicles.   The Journal of Cell Biology 104 (1987) 1-7

7. Yoshihiro Yoneda, Toshikazu Arioka, Naoko Imamoto-Sonobe, Hideo Sugawa, Yosutsugu Shimonishi  and Tsuyoshi Uchida. Synthetic peptides containing a region of SV40 large T-antigen involved in nuclear localization  direct the transport of proteins into the nucleus.    Experimental Cell Research 170 (1987) 439-452.

8. Naoko Imamoto-Sonobe, Yoshihiro Yoneda, Ryo Iwamoto, Hideo Sugawa and Tsuyoshi Uchida.  ATP-dependent association of nucler proteins with isolated rat liver nuclei.    Proceedings National Academy of Science U.S.A. 85 (1988) 3426-3430.

9. Masashi Mukoyama, Kazuwa Nakao, Hideo Sugawa, Narito Morii, Akira Sugawara, Takayuki Yamada,     Hiroshi Itoh, Shozo Shiono, Yoshihoro Saito, Hiroshi Arai, Toru Mori, Hisao Yamada, Yutaka Sano and Hiroo Imura.   A monoclonal antibody to α-human atrial natriuretic polypeptide.   Hypertension 12 (1988) 117-121.

10. Masumi Miyamoto, Hideo Sugawa, Kanji Hase, Kanji Kuma, Toru Mori and Hiroo Imura.   Epidermal growth factor receptors on cultured human thyroid cells and effects of EGF and Thyroid-    stimulating hormone on their growth.    Cancer Reseach 48 (1988) 3652-3656.

11. Hideo Sugawa, Toru Mori and Hiroo Imura.   Establishment of 8-azaguanine-resistant mutants from rat thyroid cell line FRTL-5.   Molecular and Cellular Endocrinology 62 (1989) 319-326.

12. Masumi Miyamoto, Hideo Sugawa, Kanji Kuma, Toru Mori and Hiroo Imura.     Analysis of epidermal growth factor (EGF) receptor and effect of EGF on the growth of cultured   Graves' and non-neoplastic human thyroid cells.    Journal of Endocrinological Investigation 12 (1989) 111-117.

13. Tetsuya Enomoto, Hideo Sugawa, Daisuke Inoue, Masumi Miyamoto, Shinji Kosugi, Takayuki   Takahashi, N.Kitamura, I.Yamamoto, Junji Konishi, Toru Mori and Hiroo Imura.   Establishment of human undifferentiated thyroid cancer cell line producing several growth factors  and cytokines.   Cancer 65 (1990) 1971-1979.

14. Shinji Kosugi, Daisuke Inoue, Hideo Sugawa, Tetsuya Enomoto, Toru Mori and Hiroo Imura.    Similarity and dissimilarity between clinical and laboratory findings, especially anti-thyrotropin receptor antibody in ophthalmic Graves' disease without persistent hyperthyroidism and hyperthyroid  Graves' disease.   Endocrinologia Japonica  37 (1990) 343-354.

15. Tetsuya Enomoto, Hideo Sugawa, Shinji Kosugi, Daisuke Inoue, Toru Mori and Hiroo Imura.    Prolonged-term effects of recombinant human Interleukine-1α on mouse thyroid function.   Endocrinology 127 (1990) 2322-2327.

16. Thavatchai Piraphatodist, Hideo Sugawa, Daisuke Inoue, Tetsya Enomoto, Toru Mori and Hiroo    Imura.   Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH)  receptor, which is different from TSH binding site.   Biochemical and Biophysical Research Communications 172 (1990) 529-536.

17. Toru Mori, Hideo Sugawa, Thavatchai Piraphatodist, Daisuke Inoue, Tetsuya Enomoto and Hiroo Imura.  A synthetic oligopeptide derived from human thyrotropin receptor sequence binds to Graves' immunoglobulin and inhibits thyroid stimulating antibody activity but lacks interactions with TSH.   Biochemical and Biophysical Research Communications 178 (1991) 165-172.

18. Hideo Sugawa, Masumi Miyamoto, Kayoko Higuchi, Ernest Smith, Toru Mori and Hiroo Imura. Production and properties of novel human thyroid cancer specific monoclonal antibodies.   Biochemical and Biophysical Research Communications 187 (1992) 404-412.

19. Daisuke Inoue, Kaoru Sato, Tetsuya Enomoto, Hideo Sugawa, Masahiro Maeda, Hidetoshi Inoko,  Kimiyoshi Tsuji, Toru Mori and Hiroo Imura.    Correlation of HLA tys and clinical findings in Japanese patients with hyperthyroid Graves' disease:  evidence indicating the existence of four subpopulations. Clinical Endocrinology 36 (1992) 75-82.

20. Yasumichi Ueda, Hideo Sugawa, Takashi Akamizu, Jyoji Okuda, Yukio Kihou and Toru Mori.   Immunoglobulin G that interferes with thyroid-stimulating antibody measurements can be eliminated specifically by incubation with synthetic peptides corresponding to partial sequences of the human thyrotropin receptor.   Thyroid 3 (1993) 111-117.

21. Hideo Sugawa, Ernest Smith, Hiroo Imura and Toru Mori.   A thyroid cancer specific monoclonal antibody which recognizes cryptic epitope(s) of human thyroglobulin.  Molecular and Cellular Endocrinology 93 (1993) 207-211

22. Hideo Sugawa, Mutsuo Beniko, Hiroo Imura and Toru Mori.   Characterization of epidermal growth factor receptor (EGF-R) in a rat thyroid cell line, FRTL-5.  Biochemical and Biophysical Research Communications  193 (1993) 390-397

23. 須川秀夫、松本幸子、上田路子、奥田譲治、Tuo Xian Sui、赤水尚史、森 徹   「高感度TSH CLIAベリラックスTSHの基礎的および臨床的検討」医学と薬学 自然科学社28巻5号 p1025-1030  平成4年11月 

24. Euy Kyun Shin, Fumihiko Matsuda, Junji Fujikawa, Takashi Akamizu, Hideo Sugawa, Toru Mori and     Tasuku Honjo.  Cloning of a human immunoglobulin gene fragment containing both VH-D and D-JH rearrangements:    implication for VH-D as an intermediate to VH-D-JH formation. European Journal of Immunology 23 (1993) 2365-2367

25. Euy Kyun Shin, Takashi Akamizu, Fumihiko Matsuda, Hideo Sugawa, Junji Fujikura, Toru Mori and     Tasuku Honjo    Variable-regions of immunoglobulin heavy-chain genes encoding anti-thyrotropin (TSH) receptor antibodies of patients with Graves' disease.   Journal of Immunology 152 (1994) 1485-1492

26. Toru Mori, Takashi Akamizu, Shingi Kosugi, Hideo Sugawa, Daisuke Inoue, Jyoji Okuda and Yoshimichi Ueda.    Recent progress in TSH receptor studies with a new concept of "Autoimmmune TSH Receptor Disease"    Endocrine Journal 41 (1994) 1-11

27. Daisuke Inoue, Kaoru Sato, Hideo Sugawa, takashi Akamizu, Masahiro Maeda, Hidetoshi Inoko,    Kimiyoshi Tsuju and Toru Mori   Apparent genetic difference between hypothyroid patients with blocking-type thyrotropin receptor antibody andthose without, as shown by restriction fragment length polymorphism abalyses of HLA-DP loci.   Journal of Clinical Endocrinology and Metabolism  77 (1993) 606-610

28. Norihiko Nakamura, Chihiro Azuma, Takashi Akamizu, Hideo Sugawa, Fumihiko matsuda, Nobuaki  Mitsuda, Tasuku Honjo, Toru Mori and Kenji Yamaji   Heterogeneity and diversity of IgM and IgG Lupus anticoagulants in an individual with systemic  lupus erythematosus.   Biochemical and Biophysical Research Communications 203 (1994) 1789-1794

29. Jyoji Okuda, Takashi Akamizu, Hideo Sugawa, Fumihiko Matsuda, Li Hua and Toru Mori     Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from    peripheral lymphocytes of hypothyroid patients with primary myxedema.   Journal of Clinical Endocrinology and Metabolism  79 (1994) 1600-1604

30. 渋谷雄平、井上大輔、須川秀夫、森 徹  同時性に甲状腺乳頭癌、胃癌、直腸癌を合併した一例 ―癌関連遺伝子の発現に関する免疫組織化学的検討―  日本内分泌学会雑誌 70 (1994) 951-956

31. Mei-Luo zhang, Hideo Sugawa, Shinji Kosugi and Toru mori    Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.   Biochemical and Biophysical Research Communications 211 (1995) 205-211

32. Yoshimichi Ueda, Hideo Sugawa, Takashi Akamizu, Jyoji Okuda, Michiko Ueda, Shinji Kosugi, Cizuko     Ohta, Yukio Kiho and Toru Mori   Thyroid-stimulating antibodies in sera from patients with Graves disease are heterogeneous in epitope recognition.  European Journal of endocrinology 132 (1995) 62-68

33. Hideo Sugawa, Takashi Akamizu, Shinji Kosugi, Yoshimichi Ueda, Chizuko Ohta,yoji Okuda and Toru     Mori   Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application: evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule. European Journal of endocrinology 133 (1995) 283-293  

34. Mei-Luo Zhang, Hideo Sugawa and Toru Mori  Inhibition of thyrocyte iodide uptake by HKATPase inhibitor, Timoprazole. Endocrine Journal 42 (1995) 489-496

35. Hideo Sugawa, Yoshimichi Ueda, Takashi Akamizu, Shinji Kosugi, Jyoji Okuda, Chizuko Ohta, Yoshio     Kiho and Toru Mori     Statistical analysis of functional region(s) of the TSH receptor. Journal of Endocrinol Invest 18 (1995) 710-717

36. 須川秀夫、張美洛、山岡美奈、磯部裕美、森 徹     実験動物を用いた人工的甲状腺機能低下症に対する当帰芍薬散、真武湯、抑肝散加陳皮半夏、温経湯の有用性に ついての検討 ホルモンと臨床、医学の世界社、43 (1995)  637-642

37. 小杉眞司、須川秀夫、 磯部裕美、井上大輔、森 徹  アクセスhTSHの臨床的・基礎的検討 臨床検査機器・試薬、ラボサービス、18 (1995) 791-794

38. Toru Mori, Hideo Sugawa, Takashi Akamizu, Shinji Kosugi and Jyoji Okuda     Laboratory tests necessary at the first examination of patients with suspected thyroid disorders.   Endocrine Journal 43 (1996) 197-204

39.  Shinji Kosugi, Norihito Sasaki, Noritaka Hai, Hideo Sugawa, Norihito Aoki, Chiaki Shigemasa, Toru  Mori and Akio Yoshida  Establishment and characterization of a chinese hamster ovary cell line, CHO-4J, stably expressing a number of Na+/I- symporters. Biochemical and Biophysical Research Communications 227 (1996) 94-101

40. Shinji Kosugi, Hideo Sugawa and Toru Mori   TSH receptor and LH receptor, 1996 Endocrine Journal 43 (1996) 595-604

41. Shinji Kosugi, Hideo Sugawa, and Toru Mori   Epitope analysis of the thyrotropin receptor, 1997 Molecular and Cellular Endocrinology 128 (1997) 11-18

42. Shinji Kosugi, Akira Matsuda, Noritake Hai, Norihiko Aoki, Hideo Sugawa, and Toru Mori  Aspartate-474 in the first exoplasmic loop of the thyrotropin receptor is crutial for receptor activation.  FEBS letter 406 (1997) 139-141

43. Toru Mori, Hideo Sugawa, Shinji Kosugi, Michiko Ueda, Noritaka Hai and Akira Matsuda    Recent trends in the management of Graves hyperthyroidism in Japan: Opinion Survey results, especially    on the combination of antithyroid drug and thyroid hormone.  Endocrine Journal 44 (1997) 509-517

44. Toru Mori, Hideo Sugawa, Shinji Kosugi, Michiko Ueda, Daisuke Inoue and Takashi Akamizu    Effectiveness of a short-term steroid treatment on the reduction in goiter size in antithyroid drug-treated   patients with Graves disease.   Endocrine Journal 44 (1997) 575-580

45. Hideo Sugawa, Yoshihiro Ueda, Michiko Ueda, Shinji Kosugi, Satoshi Ichiyama and Toru Mori    Immunization with the immunogenic peptide of TSH receptor induces oligoclonal antibodies with various  biological activities.     Peptides 19 (1998) 1303-1307  

46. Masahiro Amenomori, Toru Mori , Yoshihiro Fukuda, Hideo Sugawa, Naoshi Nishida, Motonobu Furukawa, Ryuichi Kita, Takehiro Sando, Toshiki Komeda and Kazuwa Nakao  Incidence and characteristics of thyroid dysfunction following interferon therapy in patients with chronic  hepatitis C. lnternal Medicine 37 (1998) 246-252

47. Akio Yoshida, Norihito Sasaki, Atsusi Mori, Shinichi Taniguchi, Yoshihiro Ueta, Kimihiko Hattori, Yasunori Tanaka, Osamu Igawa, Mariko Tsuboi, Hideo Sugawa, Ryoichi Sato, Ichiro Hisatome, Chiaki Shigemasa, Evelyn F. Grollman, Shinji Kosugi   Differences in the electrophysiological response to I- and the inhibitory anions SCN- and CLO4-, studied in FRTL-5 cells.  Biochimica et Biophysica Acta  1414 (1998) 231--237

48. Hideo Sugawa, Michiko Ueda, Akira Matsuda, Noritaka Hai, Akio Yoshida and Shinji Kosugi   Lack of measurable maximal capacity of inorganic iodide pool in non-thyroid cell.   International Journal Thyroidology, Clinical and Experimental (1998) 

49. Michiko Ueda, Hideo Sugawa, Satoshi Ichiyama and Toru Mori   Expansion of helper T cell recognition in mice immunized with a synthetic peptide corresponding to the C-terminal TSH receptor specific insert.     Peptides 20 (1999) 1085-1090 

  

(著 書)

1. 遺伝子組換え実用化技術 第3集 サイエンスフォーラム社 昭和57年 2月    「DNAの細胞への導入 

2. 動物細胞利用実用化マニュアル リアライズ社 昭和59年 8月 「赤血球ゴースト法」「赤血球膜ゴースト法」

3. 新医科学体系 細胞と細胞工学U 中山書店 昭和61年 4月   「細胞の選択培養」 「核酸及び染色体の細胞への導入」

4. 医学のあゆみ 別冊 細胞、遺伝子、免疫 −バイオテクノロジーの基本− 医歯薬出版   「融合現象を用いた巨大高分子物質の細胞内導入」 昭和61年11月

5. Annual Review 内分泌、代謝 1990 中外医学社  V内分泌、A.ホルモン一般、2.成長、増殖因子  平成2年

6. Annual Review 内分泌、代謝 1992 中外医学社  V内分泌、A.ホルモン一般、2.成長因子 平成4年

7.「検査と技術」第21巻増刊号 ”臨床化学実践マニュアル”  医学書院   「 日常検査における異常値への対応 6.酵素成分 11.ホルモン以外の生理活性物質」  平成5年3月

8. 臨床検査 第37巻  医学書院  甲状腺の検査:甲状腺癌の新しい診断法―甲状腺癌特異性モノクローナル抗体(TCM−9) 平成5年6月号

9. Progress in Endocrinology   Editor: H.Imura, K.Shizume and S.Yoshida    Elsevier Sci. Pub. 1988     Growth factors of cultured human thyroid cells.  p1063-1069   

10. The Thyroid 1988   Editor: S.Nagataki and K.Torizuka  Excerpta Medica, Amterdam  1988 Establishment of azaguanine resistant clones from FRTL5 and their application to hybridization with Graves' thyroid cells and human fibroblast.  p611-614

11. Progress in Thyroidology    Editor: M.Lee, C-S.Koh, C.J.Eastman and S.Nagataki     Korea Medical Publishing Co.  1989    Application of thyroid cancer specific monoclonal antibody to screen for the patients' sera with various thyroid diseases.       p523-526 

12. Progress in Thyroidology    Editor: M.Lee, C-S.Koh, C.J.Eastman and S.Nagataki   Korea Medical Publishing Co.  1989     Analysis of epidermal growth factor receptor of rat thyroid cell FRTL-5.   p73-76 

13. Progress in Thyroidology    Editor: M.Lee, C-S.Koh, C.J.Eastman and S.Nagataki  Korea Medical Publishing Co.  1989  Long-term effects of recombinant human interleukin 1 alpha on mouse thyroid states.  p219-222

14. Progress in Thyroidology    Editor: M.Lee, C-S.Koh, C.J.Eastman and S.Nagataki  Korea Medical Publishing Co.  1989     Analysis of phosphorylation of epidermal growth factor receptor of thyroid cancer and adjecent  non-neoplastic tissues.   p247-250 

15. 80 years of Hashimoto disease  Editor: S.Nagataki, T.Mori and K.Torizuka  Excerpta Medica   1992   Production of clonal antithyroid stimulating hormone receptor antibody producing B cell lines using Epstain-Barr virus transformation. p491-495 

16.「検査と技術」第22刊増刊号 ”免疫検査実践マニュアル” 医学書院 「T.ホルモン 2.甲状腺・副甲状腺 (3)TSH

17.「診断と治療」第85巻  診断と治療社  甲状腺疾患の基礎と臨床−最近の進歩  TSHレセプターの抗原性と抗体との関連

18. 「臨床と研究」 大道学館出版部 特集 甲状腺 機能と疾病  甲状腺ホルモンの生理作用

19.  京大漢方医学セミナー 第6回 Proceedings ライフサイエンスメディカ社  実験的甲状腺機能低下症に対する漢方薬の有用性についての検討

20 臨床薬理の進歩 97   合成ペプチドを用いたバセドウ病自己抗体の解析:合成ペプチドのバセドウ病患者血中自己抗体に対する臨床応用

21 近畿大学医学雑誌 ヨード濃縮障害患者におけるNa+/I- symporter遺伝子変異の発見

 

( 学 会 報 告 (国際学会のみ抜粋)(国内学会省略)

・国際細胞生物学会 須川秀夫、今本尚子、金田真理、内田 驍  Frog nuclear protein can accumulate in the mammalian cell nucleus even after conjugation with  exogenous protein (IgG)

First European Congress of Endocrinology   Copenhagen, Denmark  須川秀夫、井上大輔、宮本ますみ、小杉眞司、赤水尚史、西野和義、横田敏彦、中村浩淑、森 徹、井村裕夫  Isolation of 8-Azaguanine (8AG) resistant mutants from the rat thyroid cell line, FRTL5.

16th Annual meeting of the European Thyroid Association Lausanne, Switzerland    須川秀夫、小杉眞司、赤水尚史、西野和義、横田敏彦、中村浩淑、森 徹     Production of T3 and thyroglobulin in FRTL-human hybrid cells.                                                                      

International Thyroid Symposium    Tokyo, Japan   須川秀夫、森 徹、井村裕夫  Establishment of azaguanine resistant clones from FRTL-5 and their application to hybridization with Graves' thyroid cells and human fibroblast.

8th International Congress of Endocrinology        Kyoto, Japan.  須川秀夫、森 徹、井村裕夫 Long-term cultured Graves'-FRTL5 hybrid cells.

American Thyroid Association      Montreal, Canada    須川秀夫、森 徹、井村裕夫  Regulatory synthesis of human thyroglobulin from undifferentiated thyroid carcinoma by the cell  hybridization with rat thyroid cell FRTL-5.

4th Asia and Oceania Thyroid Association Meeting  Seoul, Korea 須川秀夫、宮本ますみ、隈 寛二、森 徹、井村裕夫 Application of thyroid cancer specific monoclonal antibody to screen for the patient's sera with various thyroid disease.

Asia Oceania Congress of endocrinology   Hideo Sugawa, Masumi Miyamoto, Ernest Smith, Kanji Kuma, Toru Mori and Hiroo Imura  Thyroid cancer specific monoclonal antibody TCM-9 recognizes masked epitope of thyroglobulin.

9th International Congress of Endocrinology    Nice, France. Hideo Sugawa, Tetsuya Enomoto, Takashi Akamizu, Hiroo Imura and Toru Mori   Growth stimulating immunoglobulin in patients with autoimmune thyroid diseases.

66th. American Thyroid Association   Rochester, Minesota, USA.  Hideo Sugawa, Kayoko Higuchi, Hiroo Imura and Toru Mori  Clinical application of thyroid cancer specific monoclonal antibody, TCM-9, to cytological diagnosis of thyroid nodules.

The International Hashimoto Symposium Eightieth Anniversary of Hashimoto Disease  Hideo Sugawa, Takasi Akamizu, Daisuke Inoue, Joji Okuda and Toru Mori   Production of clonal anti TSH receptor antibody producing B cell lines using EB virus transformation.

5th. Asia and Oceania Thyroid Association Meeting   Blue Mountain Australia  Hideo Sugawa, Michiko Ueda, Yasuhiro Ueda, Tuo Xian Sui and Toru Mori.   Separation of thyroid cancer specific monoclonal antibody (TCM-9) recognizing antigen from sera of patients with thyroid tumor.

・第3回 日中甲状腺会議  京都   Hideo Sugawa, Mutsuo Beniko, Hiroo Imura and Toru Mori Characterization of Epidermal growth factor receptor (EGF-R) in rat thyroid cell line, FRTL-5.

11th International thyroid meeting  Tronto, Canada   H. Sugawa, Y. Ueda, M. Zhang, S. Kosugi, M.Ueda and T. Mori. DETERMINANT SPREADING SHOWN BY MONOCLONAL THYROID STIMULATING ANTIBODY PRODUCED AGAINST A TSH RECEPTOR PEPTIDE. 

・12th Internattional thyroid congress  Kyoto, Japan  M. Ueda and H. Sugawa. THYROID SPECIFIC HELPER CELL ANALYSIS BY ELISPOT ASSAY.

・12th Internattional thyroid congress  Kyoto, Japan   N. Hai, T. Miyataku, N. Aoki, T. Imanishi, M. Watatani, H. Okamoto, H. Sugawa, T. Mori and S. Kosugi   A SECOND JAPANESE CASE WITH AN AUTONOMOUSLY FUNCTIONING THYROID NODULE (aftn) CAUSED BY A CONSTITUTIVELY ACTIVATION THYROTROPIN RECEPTOR MUTATION.